Author

Cole J. Turner

Harvard University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Anthony G. LetaiiD· 1 shared Antonio J. AlmazaniD· 1 shared Brenda C. Chan· 1 shared Cheyanne Walker-WilliamsiD· 1 shared Cloud Peter PaweletziD· 1 shared Daryl GriffiniD· 1 shared David Allen BarbieiD· 1 shared Filippo BirocchiiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Anthony G. LetaiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Drug tolerant persisters and immunotherapy persister cells exhibit cross-resistance and share common survival mechanisms

Maria Davern, Cole J. Turner, Daryl Griffin, Lara Bencsics, Brenda C. Chan, Jasmine Yun-Tong Kung, Michael Olson, Cheyanne Walker-Williams, Shaili Soni, Leah Krotee, Michael Yorsz, Gabriella Antonellis, Patrick Hall Lizotte, Cloud Peter Paweletz, Jeremy A. Ryan, , Anthony G. Letai

This study identifies common survival mechanisms between drug-tolerant persisters and immunotherapy persisters, showing they share reduced mitochondrial apoptotic sensitivity and cross-resistance to therapies.

Cell Death and Differentiation · Dec 26, 2025Peer-reviewedCancer Biology